Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).

Clinical trial NCT04893174 · UNKNOWN

Trial details

NCT number: NCT04893174
Sponsor: Meridigen Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis, Knee

Start date: 2022-09-15
Primary completion: 2024-09-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.